102 related articles for article (PubMed ID: 9502429)
1. p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cells.
Zhang L; Zhan Q; Zhan S; Kashanchi F; Fornace AJ; Seth P; Helman LJ
DNA Cell Biol; 1998 Feb; 17(2):125-31. PubMed ID: 9502429
[TBL] [Abstract][Full Text] [Related]
2. Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
Zhang L; Kashanchi F; Zhan Q; Zhan S; Brady JN; Fornace AJ; Seth P; Helman LJ
Cancer Res; 1996 Mar; 56(6):1367-73. PubMed ID: 8640827
[TBL] [Abstract][Full Text] [Related]
3. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
[TBL] [Abstract][Full Text] [Related]
4. AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma.
Zhang L; Zhan S; Navid F; Li Q; Choi YH; Kim M; Seth P; Helman LJ
Oncogene; 1998 Sep; 17(10):1261-70. PubMed ID: 9771969
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
[TBL] [Abstract][Full Text] [Related]
6. Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancer.
Zhan S; Shapiro D; Zhan S; Zhang L; Hirschfeld S; Elassal J; Helman LJ
J Biol Chem; 1995 Nov; 270(47):27983-6. PubMed ID: 7499276
[TBL] [Abstract][Full Text] [Related]
7. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
8. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.
Werner H; Karnieli E; Rauscher FJ; LeRoith D
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8318-23. PubMed ID: 8710868
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
10. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
[TBL] [Abstract][Full Text] [Related]
11. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
12. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the P4 promoter region of the human insulin-like growth factor II gene.
Hyun SW; Kim SJ; Park K; Rho HM; Lee YI
FEBS Lett; 1993 Oct; 332(1-2):153-8. PubMed ID: 8405433
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein phosphatases activates P4 promoter of the human insulin-like growth factor II gene through the specific promoter element.
Hyun SW; Park K; Lee YS; Lee YI; Kim SJ
J Biol Chem; 1994 Jan; 269(1):364-8. PubMed ID: 8276819
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
16. Dual role for transcription factor AP-2 in the regulation of the major fetal promoter P3 of the gene for human insulin-like growth factor II.
Rietveld LE; Koonen-Reemst AM; Sussenbach JS; Holthuizen PE
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):799-806. PubMed ID: 10051455
[TBL] [Abstract][Full Text] [Related]
17. Identification of a key regulatory element for the basal activity of the human insulin-like growth factor II gene promoter P3.
Rietveld LE; Holthuizen PE; Sussenbach JS
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):689-97. PubMed ID: 9581544
[TBL] [Abstract][Full Text] [Related]
18. Differential promoter activation in two human insulin-like growth factor-II-producing tumor cell lines.
Schneid H; Holthuizen PE; Sussenbach JS
Endocrinology; 1993 Mar; 132(3):1145-50. PubMed ID: 8382597
[TBL] [Abstract][Full Text] [Related]
19. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
